Oct 1 (Reuters) – Sanofi and US partner Regeneron on Thursday said they would expand their partnership to develop four new drugs, in a deal that includes up to $7 billion in milestone payments. Sanofi
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Dow futures hit three-month low as yields surge, Micron earnings offer support
Oct 1 (Reuters) - Dow futures slipped to a more than three-month low on Thursday…
Fritz, Ruud, Nakashima exit as upsets hit Japan Open
VIDEO SHOWS: ATP 500 JAPAN OPEN FIRST ROUND HIGHLIGHTS RESENDING WITH COMPLETE SHOTLIST SHOWS: TOKYO,…
Oct 1 (OPTA) - Summaries for the MLS on Wednesday (start times are EST) New…
